Laboratoires Goemar
Records under this name other than the patents Laboratoires Goemar holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,505,774 | Fluid delivery device Formerly held Lapsed on the fee record Ended Aug 13, 2025 · From the USPTO record | Lapsed on the fee record | Ended Aug 13, 2025 | From the USPTO record |
| US 6,979,665 | Agent for stimulation of the natural defences of plants and methods for using it Term ended Term ended Mar 12, 2023 · From the USPTO record | Term ended | Term ended Mar 12, 2023 | From the USPTO record |
| US 6,451,352 | Use of iso-osmotic saline solutions, method for preparing same and medicine based on said solutions Formerly held Term ended Term ended May 24, 2021 · From the USPTO record | Term ended | Term ended May 24, 2021 | From the USPTO record |
| US 6,511,838 | Genes coding for &bgr;-agarases and their use for producing agar biodegradation enzymes Term ended Term ended Dec 12, 2020 · From the USPTO record | Term ended | Term ended Dec 12, 2020 | From the USPTO record |
| US 6,387,847 | Method for stimulating natural control system of plants Term ended Term ended Jan 18, 2020 · From the USPTO record | Term ended | Term ended Jan 18, 2020 | From the USPTO record |
| US 6,984,630 | Endofucanases and method using same for preparing fuco-oligosaccharides from fucanes, bacterium producing endofucanases and uses of fuco-oligosaccharides for plant protection Term ended Term ended Sep 21, 2019 · From the USPTO record | Term ended | Term ended Sep 21, 2019 | From the USPTO record |
| US 6,921,540 | Hypoosmotic saline solutions, method for preparing same and medicines based on said solution Formerly held Term ended Term ended Jul 5, 2019 · From the USPTO record | Term ended | Term ended Jul 5, 2019 | From the USPTO record |
| US 6,333,185 | Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans Term ended Term ended Apr 5, 2019 · From the USPTO record | Term ended | Term ended Apr 5, 2019 | From the USPTO record |
| US 7,070,778 | Therapeutical combination against cancer Lapsed on the fee record Ended Jul 4, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jul 4, 2018 | From the USPTO record |
| US 7,008,931 | Anti-inflammatory and healing medicine based on laminarin sulphate Lapsed on the fee record Ended Mar 7, 2018 · From the USPTO record | Lapsed on the fee record | Ended Mar 7, 2018 | From the USPTO record |